|
Atomistry » Chlorine » PDB 6g8l-6ggl » 6g91 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Chlorine » PDB 6g8l-6ggl » 6g91 » |
Chlorine in PDB 6g91: Fragment-Based Discovery of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2Enzymatic activity of Fragment-Based Discovery of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2
All present enzymatic activity of Fragment-Based Discovery of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2:
2.7.11.24; Protein crystallography data
The structure of Fragment-Based Discovery of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2, PDB code: 6g91
was solved by
M.O'reilly,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Fragment-Based Discovery of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2
(pdb code 6g91). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Fragment-Based Discovery of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2, PDB code: 6g91: Chlorine binding site 1 out of 1 in 6g91Go back to Chlorine Binding Sites List in 6g91
Chlorine binding site 1 out
of 1 in the Fragment-Based Discovery of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates the Phosphorylation and Catalytic Activity of ERK1/2
Mono view Stereo pair view
Reference:
T.D.Heightman,
V.Berdini,
H.Braithwaite,
I.M.Buck,
M.Cassidy,
J.Castro,
A.Courtin,
J.E.H.Day,
C.East,
L.Fazal,
B.Graham,
C.M.Griffiths-Jones,
J.F.Lyons,
V.Martins,
S.Muench,
J.M.Munck,
D.Norton,
M.O'reilly,
N.Palmer,
P.Pathuri,
M.Reader,
D.C.Rees,
S.J.Rich,
C.Richardson,
H.Saini,
N.T.Thompson,
N.G.Wallis,
H.Walton,
N.E.Wilsher,
A.J.Woolford,
M.Cooke,
D.Cousin,
S.Onions,
J.Shannon,
J.Watts,
C.W.Murray.
Fragment-Based Discovery of A Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2. J. Med. Chem. V. 61 4978 2018.
Page generated: Sat Jul 27 23:52:27 2024
ISSN: ISSN 1520-4804 PubMed: 29775310 DOI: 10.1021/ACS.JMEDCHEM.8B00421 |
Last articlesZn in 9JPJZn in 9JP7 Zn in 9JPK Zn in 9JPL Zn in 9GN6 Zn in 9GN7 Zn in 9GKU Zn in 9GKW Zn in 9GKX Zn in 9GL0 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |